Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
This guide examines ETFs that tend to minimize taxes in taxable accounts, helping you identify tax-efficient options. Learn how to apply these picks to improve after-tax returns.
22,091 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Regulators are weighing changes to mortgage asset rules, yet banks may take time to adjust. In the near term, mortgag...
PepsiCo stock faces a potential move toward $180 as analysts cite World Cup-driven demand, cost cuts, and internation...
The Digital Chamber launches the Prediction Markets Working Group to win federal oversight for prediction markets, se...
Delta CEO Ed Bastian says cheaper fares depend on expanding capacity and easing air-traffic flow, marking a shift in ...
Oklo has zigzagged from a peak near $193 to much lower levels, raising questions about its momentum and prospects. Th...
Is SpaceX a smarter buy than the Magnificent Seven it briefly rivaled in market value? This analysis weighs growth, p...
Buying nebius group stock represents a high-conviction AI infrastructure play. This guide breaks down the business, m...
A Beverly Hills estate valued at $63 million has added a custom doggy mansion on its grounds, spotlighting how celebr...
MicroStrategy confronts a pivotal test as its Bitcoin treasury faces a brutal market. With BTC below its purchase pri...
Nvidia is fueling a bold thesis for H2 2026 as AI infrastructure demand climbs. With data-center momentum and locked-...
Costco's path for 2026-2030 hinges on membership economics, pricing power, and macro demand. This report outlines bas...